In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains

[1]  V. Vicente,et al.  Microbiological and virulence aspects of Rhodotorula mucilaginosa , 2020, EXCLI journal.

[2]  H. Hof.  Rhodotorula spp. in the gut – foe or friend? , 2019, GMS infectious diseases.

[3]  Liuping Zhang,et al.  The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence , 2016, Antimicrobial Agents and Chemotherapy.

[4]  Rongya Yang,et al.  In Vitro Interactions between Non-Steroidal Anti-Inflammatory Drugs and Antifungal Agents against Planktonic and Biofilm Forms of Trichosporon asahii , 2016, PloS one.

[5]  Liuping Zhang,et al.  Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans , 2016, PloS one.

[6]  D. Castelo-Branco,et al.  Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species , 2015, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[7]  A. Armaganidis,et al.  Rhodotorula mucilaginosa associacted meningitis: A subacute entity with high mortality. Case report and review , 2014, Medical mycology case reports.

[8]  Chenghang Sun,et al.  In Vitro Interactions of Calcineurin Inhibitors with Conventional Antifungal Agents Against the Yeast Form of Penicillium marneffei , 2014, Mycopathologia.

[9]  T. J. Bandeira,et al.  The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. , 2014, Journal of medical microbiology.

[10]  J. Martinez-de-Oliveira,et al.  Anti-Candida Activity of Fluoxetine Alone and Combined with Fluconazole: a Synergistic Action against Fluconazole-Resistant Strains , 2014, Antimicrobial Agents and Chemotherapy.

[11]  J Polanski,et al.  Synergy against fungal pathogens: working together is better than working alone. , 2014, Current medicinal chemistry.

[12]  J. Heitman,et al.  Calcineurin Controls Hyphal Growth, Virulence, and Drug Tolerance of Candida tropicalis , 2014, Eukaryotic Cell.

[13]  S. Kocsubé,et al.  Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. , 2013, Medical mycology.

[14]  J. Fariña,et al.  Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification. , 2013, Revista iberoamericana de micologia.

[15]  Jun Kato,et al.  Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[16]  S. H. Alves,et al.  In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp. , 2011, Diagnostic microbiology and infectious disease.

[17]  P. Shukla,et al.  Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans. , 2010, Fungal biology.

[18]  F. Tuon,et al.  Rhodotorula infection. A systematic review of 128 cases from literature. , 2008, Revista iberoamericana de micologia.

[19]  M. Burattini,et al.  Rhodotorula spp. isolated from blood cultures: clinical and microbiological aspects. , 2008, Medical mycology.

[20]  Shujuan Sun,et al.  Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. , 2008, Journal of medical microbiology.

[21]  J. Heitman,et al.  Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms , 2008, Antimicrobial Agents and Chemotherapy.

[22]  Shujuan Sun,et al.  In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods , 2007, Antimicrobial Agents and Chemotherapy.

[23]  R. Rosenson,et al.  Statins and sepsis: multiple modifications at multiple levels. , 2007, The Lancet. Infectious diseases.

[24]  Russell E. Lewis,et al.  Lovastatin Has Significant Activity against Zygomycetes and Interacts Synergistically with Voriconazole , 2006, Antimicrobial Agents and Chemotherapy.

[25]  M. Pfaller,et al.  Activities of Available and Investigational Antifungal Agents against Rhodotorula Species , 2005, Journal of Clinical Microbiology.

[26]  M. Cuenca‐Estrella.  Combinations of antifungal agents in therapy--what value are they? , 2004, The Journal of antimicrobial chemotherapy.

[27]  M. Dierich,et al.  Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro. , 2004, International journal of antimicrobial agents.

[28]  M. Pfaller,et al.  Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus , 2004, Journal of Clinical Microbiology.

[29]  M. Bard,et al.  Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. , 2004, The Journal of antimicrobial chemotherapy.

[30]  J. Perfect,et al.  Combination Antifungal Therapy , 2004, Antimicrobial Agents and Chemotherapy.

[31]  A. Zaas,et al.  Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates , 2003, Journal of Clinical Microbiology.

[32]  G. S. de Hoog,et al.  In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera. , 2003, The Journal of antimicrobial chemotherapy.

[33]  K. Yokoyama,et al.  Molecular phylogenetics of the genus Rhodotorula and related basidiomycetous yeasts inferred from the mitochondrial cytochrome b gene. , 2001, International journal of systematic and evolutionary microbiology.

[34]  L. Gyüre,et al.  Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans , 2000, Mycoses.

[35]  R. J. Koch,et al.  Possible role of anticoagulation in the treatment of rhinocerebral mucormycosis , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[36]  C. Sánchez,et al.  Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding , 1999, Cellular and Molecular Neurobiology.

[37]  J. Sobel,et al.  High-Frequency, In Vitro Reversible Switching of Candida lusitaniae Clinical Isolates from Amphotericin B Susceptibility to Resistance , 1999, Antimicrobial Agents and Chemotherapy.

[38]  R. Chen,et al.  Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs , 1997, Antimicrobial agents and chemotherapy.

[39]  M. Tanaka,et al.  In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi , 1995, Antimicrobial agents and chemotherapy.

[40]  I. Salkin.  The times are a-changing. , 2014, Medical mycology.

[41]  D. Ellis.  Amphotericin B: spectrum and resistance. , 2002, The Journal of antimicrobial chemotherapy.

[42]  T. Flanigan,et al.  A fatal case of Rhodotorula meningitis in AIDS. , 1998, Medicine and health, Rhode Island.

[43]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .

[44]  T. Rogers,et al.  In-vitro activity of antifungal agents in combination with four quinolones. , 1988, Drugs under experimental and clinical research.